APA (7th ed.) Citation

Gonzalez-Miro, M., Pawlowski, A., Lehtonen, J., Cao, D., Larsson, S., Darsley, M., . . . Johansson-Lindbom, B. (2023). Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial. Elsevier.

Chicago Style (17th ed.) Citation

Gonzalez-Miro, Majela, Andrzej Pawlowski, Janne Lehtonen, Duojia Cao, Sara Larsson, Michael Darsley, Geoff Kitson, Per B. Fischer, and Bengt Johansson-Lindbom. Safety and Immunogenicity of the Group B Streptococcus Vaccine AlpN in a Placebo-controlled Double-blind Phase 1 Trial. Elsevier, 2023.

MLA (9th ed.) Citation

Gonzalez-Miro, Majela, et al. Safety and Immunogenicity of the Group B Streptococcus Vaccine AlpN in a Placebo-controlled Double-blind Phase 1 Trial. Elsevier, 2023.